Jim Simons Sarepta Therapeutics, Inc. Transaction History

Renaissance Technologies LLC

$70.6 Billion
Q3 2025

A detailed history of Jim Simons (Renaissance Technologies LLC) transactions in Sarepta Therapeutics, Inc. stock. As of the latest transaction made, Renaissance Technologies LLC holds 2,650,178 shares of SRPT stock, worth $49.8 Million. This represents 0.07% of its overall portfolio holdings.

Number of Shares

2,650,178

Previous 624,478 324.38%

Holding current value

$49.8 Million

Previous $10.7 Million 378.25%

% of portfolio

0.07%

Previous 0.02%

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2025 Nov 13, 2025	BUY	$11.93 - $21.97 $24.2 Million - $44.5 Million	2,025,700 Added 324.38%	2,650,178 $51.1 Million
Q2 2025 Aug 13, 2025	BUY	$17.1 - $63.66 $10.7 Million - $39.8 Million	624,478 New	624,478 $10.7 Million
Q3 2024 Nov 13, 2024	SELL	$124.33 - $156.75 $15.1 Million - $19 Million	-121,522 Reduced 34.52%	230,478 $28.8 Million
Q2 2024 Aug 09, 2024	SELL	$113.33 - $163.85 $4.34 Million - $6.27 Million	-38,278 Reduced 9.81%	352,000 $55.6 Million
Q1 2024 May 13, 2024	SELL	$93.7 - $141.53 $16.2 Million - $24.4 Million	-172,700 Reduced 30.68%	390,278 $50.5 Million
Q4 2023 Feb 13, 2024	SELL	$67.31 - $124.76 $8.07 Million - $15 Million	-119,900 Reduced 17.56%	562,978 $54.3 Million
Q3 2023 Nov 14, 2023	BUY	$102.5 - $123.59 $4.18 Million - $5.04 Million	40,800 Added 6.35%	682,878 $82.8 Million
Q2 2023 Aug 11, 2023	SELL	$106.4 - $157.19 $17.5 Million - $25.8 Million	-164,400 Reduced 20.38%	642,078 $73.5 Million
Q1 2023 May 12, 2023	BUY	$117.53 - $155.99 $10.3 Million - $13.7 Million	87,600 Added 12.19%	806,478 $111 Million
Q4 2022 Feb 13, 2023	SELL	$100.86 - $132.13 $16.7 Million - $21.8 Million	-165,300 Reduced 18.7%	718,878 $93.2 Million
Q3 2022 Nov 14, 2022	BUY	$75.71 - $119.24 $37.2 Million - $58.5 Million	490,900 Added 124.82%	884,178 $97.7 Million
Q2 2022 Aug 12, 2022	BUY	$62.69 - $88.44 $15.3 Million - $21.6 Million	244,478 Added 164.3%	393,278 $29.5 Million
Q1 2022 May 13, 2022	SELL	$63.15 - $90.42 $5.48 Million - $7.85 Million	-86,778 Reduced 36.84%	148,800 $11.6 Million
Q4 2021 Feb 11, 2022	BUY	$77.28 - $99.42 $17.5 Million - $22.6 Million	227,078 Added 2671.51%	235,578 $21.2 Million
Q3 2021 Nov 12, 2021	SELL	$65.97 - $92.48 $7.88 Million - $11 Million	-119,478 Reduced 93.36%	8,500 $786,000
Q2 2021 Aug 13, 2021	BUY	$69.38 - $86.75 $8.88 Million - $11.1 Million	127,978 New	127,978 $9.95 Million
Q4 2020 Feb 10, 2021	SELL	$125.56 - $178.74 $19.7 Million - $28 Million	-156,578 Closed	0 $0
Q3 2020 Nov 13, 2020	SELL	$127.12 - $172.34 $38.1 Million - $51.7 Million	-299,900 Reduced 65.7%	156,578 $22 Million
Q2 2020 Aug 13, 2020	BUY	$93.0 - $171.7 $35 Million - $64.7 Million	376,800 Added 472.9%	456,478 $73.2 Million
Q1 2020 May 14, 2020	BUY	$82.38 - $131.64 $6.56 Million - $10.5 Million	79,678 New	79,678 $7.79 Million
Q4 2019 Feb 13, 2020	SELL	$76.53 - $135.58 $26.6 Million - $47.2 Million	-348,078 Closed	0 $0
Q3 2019 Nov 13, 2019	BUY	$72.81 - $156.91 $18.6 Million - $40 Million	255,200 Added 274.77%	348,078 $26.2 Million
Q2 2019 Aug 12, 2019	BUY	$112.21 - $151.95 $10.4 Million - $14.1 Million	92,878 New	92,878 $14.1 Million

Others Institutions Holding SRPT

# of Institutions

412

Shares Held

153M

Call Options Held

5.44M

Put Options Held

6.09M

View Full List

About Sarepta Therapeutics, Inc.

Ticker SRPT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 87,567,904
Market Cap $1.65B
Description
Sarepta Therapeutics, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery and development of RNA-targeted therapeutics, gene therapies, and other genetic therapeutic modalities for the treatment of rare diseases. It offers EXONDYS 51 injection to treat duchenne muscular dystrophy (duchenne) in patients with confirmed mut...

More about SRPT

Track Jim Simons's Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Renaissance Technologies LLC, based on Form 13F filings with the SEC.

News

Stay updated on Renaissance Technologies LLC and Jim Simons with notifications on news.

Account